These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
|||||||
|
(State or Other Jurisdiction of
Incorporation or Organization) |
(I.R.S. Employer
Identification No.) |
|||||||
|
|
|||||||||||
|
|
|
|
|||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
| Large accelerated filer | ¨ |
|
x | Smaller reporting company |
|
||||||||||||||||||
| Non-accelerated filer |
¨
|
Emerging growth company |
|
||||||||||||||||||||
| Page | |||||||||||
|
Item 3
.
|
|||||||||||
| June 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Accounts and other receivables, net |
|
|
|||||||||
| Income taxes recoverable |
|
|
|||||||||
| Inventories |
|
|
|||||||||
| Prepaid expenses and other |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property, plant and equipment, at cost |
|
|
|||||||||
| Less: accumulated depreciation |
(
|
(
|
|||||||||
| Net property, plant and equipment |
|
|
|||||||||
| Right-of-use leased assets |
|
|
|||||||||
| Identifiable intangible assets, net |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Noncurrent assets of discontinued operations |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued expenses |
|
|
|||||||||
| Lease liability, short-term |
|
|
|||||||||
| Short-term debt |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| Current liabilities of discontinued operations |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Lease liability, long-term |
|
|
|||||||||
| ABL revolving facility |
|
|
|||||||||
| Pension and other postretirement benefit obligations, net |
|
|
|||||||||
| Deferred income tax liabilities |
|
|
|||||||||
| Other non-current liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Shareholders’ equity: | |||||||||||
|
Common stock, no par value (authorized shares
|
|
|
|||||||||
|
Common stock held in trust for savings restoration plan (
|
(
|
(
|
|||||||||
| Accumulated other comprehensive income (loss): | |||||||||||
| Foreign currency translation adjustment |
|
|
|||||||||
| Gain (loss) on derivative financial instruments |
|
|
|||||||||
| Pension and other postretirement benefit adjustments |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Total shareholders’ equity |
|
|
|||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
|||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Revenues and other items: | |||||||||||||||||||||||
| Sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other income (expense), net |
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Cost of goods sold |
|
|
|
|
|||||||||||||||||||
| Freight |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
| Research and development |
|
(
|
|
|
|||||||||||||||||||
| Amortization of identifiable intangibles |
|
|
|
|
|||||||||||||||||||
| Pension and postretirement benefits |
|
|
|
|
|||||||||||||||||||
| Interest expense |
|
|
|
|
|||||||||||||||||||
| Asset impairments and costs associated with exit and disposal activities, net of adjustments |
(
|
|
|
|
|||||||||||||||||||
| Total |
|
|
|
|
|||||||||||||||||||
| Income (loss) from continuing operations before income taxes |
|
|
|
|
|||||||||||||||||||
| Income tax expense (benefit) |
|
(
|
|
|
|||||||||||||||||||
| Net income (loss) from continuing operations |
|
|
|
|
|||||||||||||||||||
| Income (loss) from discontinued operations, net of tax |
(
|
(
|
|
|
|||||||||||||||||||
| Net income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Earnings (loss) per share: | |||||||||||||||||||||||
| Basic: | |||||||||||||||||||||||
| Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Discontinued operations |
|
(
|
|
|
|||||||||||||||||||
| Basic earnings (loss) per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted: | |||||||||||||||||||||||
| Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Discontinued operations |
|
(
|
|
|
|||||||||||||||||||
| Diluted earnings (loss) per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Shares used to compute earnings (loss) per share: | |||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||
| Three Months Ended June 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net income (loss) | $ |
|
$ |
|
|||||||
| Other comprehensive income (loss): | |||||||||||
|
Unrealized foreign currency translation adjustment ($
|
|
(
|
|||||||||
|
Derivative financial instruments adjustment (net of tax expense of $
|
|
(
|
|||||||||
|
Amortization of prior service costs and net gains or losses (net of tax benefit of $
|
(
|
(
|
|||||||||
| Other comprehensive income (loss) |
|
(
|
|||||||||
| Comprehensive income (loss) | $ |
|
$ |
|
|||||||
| Six Months Ended June 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net income (loss) | $ |
|
$ |
|
|||||||
| Other comprehensive income (loss): | |||||||||||
|
Unrealized foreign currency translation adjustment ($
|
|
(
|
|||||||||
|
Derivative financial instruments adjustment (net of tax expense of $
|
|
(
|
|||||||||
|
Amortization of prior service costs and net gains or losses (net of tax benefit of $
|
(
|
(
|
|||||||||
| Other comprehensive income (loss) |
|
(
|
|||||||||
| Comprehensive income (loss) | $ |
|
$ |
|
|||||||
| Six Months Ended June 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ |
|
$ |
|
|||||||
| Adjustments for noncash items: | |||||||||||
| Depreciation |
|
|
|||||||||
| Amortization of identifiable intangibles |
|
|
|||||||||
| Reduction of right-of-use lease asset |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Accrued pension and post-retirement benefits |
|
|
|||||||||
| Stock-based compensation expense |
|
|
|||||||||
| Gain on investment in kaléo |
|
(
|
|||||||||
| Gain on the sale of assets |
(
|
|
|||||||||
| Gain on the sale of divested business |
(
|
|
|||||||||
| Changes in assets and liabilities: | |||||||||||
| Accounts and other receivables |
(
|
(
|
|||||||||
| Inventories |
(
|
(
|
|||||||||
| Income taxes recoverable/payable |
(
|
(
|
|||||||||
| Prepaid expenses and other |
|
|
|||||||||
| Accounts payable and accrued expenses |
|
|
|||||||||
| Lease liability |
(
|
(
|
|||||||||
| Pension and postretirement benefit plan contributions |
(
|
(
|
|||||||||
| Other, net |
|
|
|||||||||
| Net cash provided by (used in) operating activities |
(
|
|
|||||||||
| Cash flows from investing activities: | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Proceeds from the sale of Terphane |
|
|
|||||||||
| Proceeds on sale of investment in kaléo |
|
|
|||||||||
| Proceeds from the sale of assets |
|
|
|||||||||
| Net cash provided by (used in) investing activities |
|
(
|
|||||||||
| Cash flows from financing activities: | |||||||||||
| Borrowings |
|
|
|||||||||
| Debt principal payments |
(
|
(
|
|||||||||
| Debt financing costs |
(
|
(
|
|||||||||
| Net cash provided by (used in) financing activities |
(
|
(
|
|||||||||
| Effect of exchange rate changes on cash |
|
(
|
|||||||||
| Increase (decrease) in cash and cash equivalents |
|
(
|
|||||||||
| Cash and cash equivalents at beginning of period |
|
|
|||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||
| Common Stock | Retained Earnings | Trust for Savings Restoration Plan | Accumulated Other Comprehensive Income (Loss) | Total Shareholders’ Equity | |||||||||||||||||||||||||
|
Balance April 1, 2025
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income (loss) | — |
|
— | — |
|
||||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — |
|
|
||||||||||||||||||||||||
| Derivative financial instruments adjustment | — | — | — |
|
|
||||||||||||||||||||||||
| Amortization of prior service costs and net gains or losses | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Stock-based compensation expense |
|
— | — | — |
|
||||||||||||||||||||||||
| Repurchase of employee common stock for tax withholdings |
(
|
— | — | — |
(
|
||||||||||||||||||||||||
|
Balance June 30, 2025
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Common Stock | Retained Earnings | Trust for Savings Restoration Plan | Accumulated Other Comprehensive Income (Loss) | Total Shareholders’ Equity | |||||||||||||||||||||||||
|
Balance January 1, 2025
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income (loss) | — |
|
— | — |
|
||||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — |
|
|
||||||||||||||||||||||||
| Derivative financial instruments adjustment | — | — | — |
|
|
||||||||||||||||||||||||
| Amortization of prior service costs and net gains or losses | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Stock-based compensation expense |
|
— | — | — |
|
||||||||||||||||||||||||
| Repurchase of employee common stock for tax withholdings |
(
|
— | — | — |
(
|
||||||||||||||||||||||||
|
Balance June 30, 2025
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
|
Common
Stock |
Retained
Earnings |
Trust for
Savings Restoration Plan |
Accumulated Other
Comprehensive Income (Loss) |
Total
Shareholders’ Equity |
|||||||||||||||||||||||||
| Balance at April 1, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Net income (loss) | — |
|
— | — |
|
||||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Derivative financial instruments adjustment | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Amortization of prior service costs and net gains or losses | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Stock-based compensation expense |
|
— | — | — |
|
||||||||||||||||||||||||
| Balance at June 30, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
|
Common
Stock |
Retained
Earnings |
Trust for
Savings Restoration Plan |
Accumulated Other
Comprehensive Income (Loss) |
Total
Shareholders’ Equity |
|||||||||||||||||||||||||
| Balance at January 1, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Net income (loss) | — |
|
— | — |
|
||||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Derivative financial instruments adjustment | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Amortization of prior service costs and net gains or losses | — | — | — |
(
|
(
|
||||||||||||||||||||||||
| Stock-based compensation expense |
|
— | — | — |
|
||||||||||||||||||||||||
| Repurchase of employee common stock for tax withholdings |
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Balance at June 30, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | |||||||||
| Customer receivables | $ |
|
$ |
|
|||||||
| Other receivables |
|
|
|||||||||
| Total accounts and other receivables |
|
|
|||||||||
| Less: Allowance for bad debts |
(
|
(
|
|||||||||
| Total accounts and other receivables, net | $ |
|
$ |
|
|||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | |||||||||
| Finished goods | $ |
|
$ |
|
|||||||
| Work-in-process |
|
|
|||||||||
| Raw materials |
|
|
|||||||||
| Stores, supplies and other |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| Pension Benefits | Other Post-Retirement Benefits | ||||||||||||||||||||||
| Three Months Ended June 30, | Three Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Interest cost |
|
|
|
|
|||||||||||||||||||
| Amortization of prior service costs, (gains) losses and net transition asset |
|
|
(
|
(
|
|||||||||||||||||||
| Net periodic benefit cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Pension Benefits | Other Post-Retirement Benefits | ||||||||||||||||||||||
| Six Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Interest cost |
|
|
|
|
|||||||||||||||||||
| Amortization of prior service costs, (gains) losses and net transition asset |
|
|
(
|
(
|
|||||||||||||||||||
| Net periodic benefit cost | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Weighted average shares outstanding used to compute basic earnings per share |
|
|
|
|
|||||||||||||||||||
| Incremental dilutive shares attributable to stock options and restricted stock |
|
|
|
|
|||||||||||||||||||
| Shares used to compute diluted earnings per share |
|
|
|
|
|||||||||||||||||||
| (In thousands) | Foreign Currency Translation | Gain (Loss) on Derivative Financial Instruments | Pension & Other Postretirement Benefit Adjust | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
| Balance at April 1, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other comprehensive income (loss) |
|
|
|
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
(
|
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
|
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss) |
|
|
(
|
(
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
(
|
|
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss), net of tax |
|
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
(
|
|
|||||||||||||||||||
|
Balance at June 30, 2025
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| (In thousands) | Foreign Currency Translation | Gain (Loss) on Derivative Financial Instruments | Pension & Other Postretirement Benefit Adjust | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
| Balance at January 1, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other comprehensive income (loss) |
|
|
|
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
(
|
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
|
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss) |
|
|
(
|
(
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
(
|
|
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss), net of tax |
|
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
(
|
|
|||||||||||||||||||
|
Balance at June 30, 2025
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| (In thousands) | Foreign Currency Translation | Gain (Loss) on Derivative Financial Instruments | Pension & Other Postretirement Benefit Adjust | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
| Balance at April 1, 2024 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
|
|
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
(
|
(
|
|
(
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss) |
|
|
(
|
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
(
|
|
(
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss), net of tax |
|
|
(
|
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Balance at June 30, 2024
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| (In thousands) | Foreign Currency Translation | Gain (Loss) on Derivative Financial Instruments | Pension & Other Postretirement Benefit Adjust | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
| Balance at January 1, 2024 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
|
|
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
(
|
(
|
|
(
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss) |
|
(
|
(
|
(
|
|||||||||||||||||||
| Income tax (expense) benefit |
|
|
|
|
|||||||||||||||||||
| Reclassification adjustment to net income (loss), net of tax |
|
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Balance at June 30, 2024
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| June 30, 2025 | December 31, 2024 | ||||||||||||||||||||||
| (In thousands) |
Balance Sheet
Account |
Fair
Value |
Balance Sheet
Account |
Fair
Value |
|||||||||||||||||||
| Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||
|
Asset derivatives:
Aluminum futures contracts
|
Prepaid expenses and other | $ |
|
Prepaid expenses and other | $ |
|
|||||||||||||||||
|
Asset derivatives:
Aluminum futures contracts
|
Other assets |
|
Other assets |
|
|||||||||||||||||||
|
Liability derivatives:
Aluminum futures contracts
|
Accrued expenses |
|
Accrued expenses |
(
|
|||||||||||||||||||
| Net asset (liability) | $ |
|
$ |
|
|||||||||||||||||||
| Cash Flow Derivative Hedges | |||||||||||
| Three Months Ended June 30, | |||||||||||
| Aluminum Futures Contracts | |||||||||||
| (In thousands) | 2025 | 2024 | |||||||||
| Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | $ |
|
$ |
(
|
|||||||
| Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold | Cost of goods sold | |||||||||
| Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | $ |
(
|
$ |
(
|
|||||||
| Six Months Ended June 30, | |||||||||||
| Aluminum Futures Contracts | |||||||||||
| 2025 | 2024 | ||||||||||
| Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | $ |
|
$ |
|
|||||||
| Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold | Cost of goods sold | |||||||||
| Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | $ |
(
|
$ |
(
|
|||||||
| Three Months Ended June 30, 2025 | |||||||||||||||||
| (In thousands) | Aluminum Extrusions | PE Films | Total | ||||||||||||||
| Net Sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of revenue: | |||||||||||||||||
| Add back freight |
|
||||||||||||||||
| Sales as shown in the consolidated statements of income (loss) | $ |
|
|||||||||||||||
| Less: | |||||||||||||||||
| Variable costs | $ |
|
$ |
|
$ |
|
|||||||||||
|
Manufacturing fixed costs
1
|
|
|
|
||||||||||||||
|
Selling, general and administrative costs
1
|
|
|
|
||||||||||||||
|
Other
2
|
|
|
|
||||||||||||||
| EBITDA from ongoing operations | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of profit (loss): | |||||||||||||||||
| Depreciation and amortization |
|
||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other |
|
||||||||||||||||
| Interest income |
|
||||||||||||||||
| Interest expense |
|
||||||||||||||||
|
Corporate expenses, net
3
|
|
||||||||||||||||
| Income (loss) from continuing operations before income tax |
|
||||||||||||||||
| Income tax expense (benefit) |
|
||||||||||||||||
| Net income (loss) from continuing operations |
|
||||||||||||||||
| Income (loss) from discontinued operations, net of tax |
(
|
||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||
|
1. Excludes related depreciation and amortization.
2. Includes segment allocated employee compensation benefit expenses. 3. Includes corporate depreciation and amortization. |
|||||||||||||||||
| Three Months Ended June 30, 2024 | |||||||||||||||||
| (In thousands) | Aluminum Extrusions | PE Films | Total | ||||||||||||||
| Net Sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of revenue: | |||||||||||||||||
| Add back freight |
|
||||||||||||||||
| Sales as shown in the consolidated statements of income (loss) | $ |
|
|||||||||||||||
| Less: | |||||||||||||||||
| Variable costs | $ |
|
$ |
|
$ |
|
|||||||||||
|
Manufacturing fixed costs
1
|
|
|
|
||||||||||||||
|
Selling, general and administrative costs
1
|
|
|
|
||||||||||||||
|
Other
2
|
(
|
(
|
(
|
||||||||||||||
| EBITDA from ongoing operations | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of profit (loss): | |||||||||||||||||
| Depreciation and amortization |
|
||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other |
|
||||||||||||||||
| Interest income |
|
||||||||||||||||
| Interest expense |
|
||||||||||||||||
| Gain on investment in kaleo, Inc. |
|
||||||||||||||||
|
Corporate expenses, net
3
|
|
||||||||||||||||
| Income (loss) from continuing operations before income tax |
|
||||||||||||||||
| Income tax expense (benefit) |
(
|
||||||||||||||||
| Net income (loss) from continuing operations |
|
||||||||||||||||
| Income (loss) from discontinued operations, net of tax |
(
|
||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||
|
1. Excludes related depreciation and amortization.
2. Includes segment allocated employee compensation benefit expenses. 3. Includes corporate depreciation and amortization. |
|||||||||||||||||
| Six Months Ended June 30, 2025 | |||||||||||||||||
| (In thousands) | Aluminum Extrusions | PE Films | Total | ||||||||||||||
| Net Sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of revenue: | |||||||||||||||||
| Add back freight |
|
||||||||||||||||
| Sales as shown in the consolidated statements of income (loss) | $ |
|
|||||||||||||||
| Less: | |||||||||||||||||
| Variable costs | $ |
|
$ |
|
$ |
|
|||||||||||
|
Manufacturing fixed costs
1
|
|
|
|
||||||||||||||
|
Selling, general and administrative costs
1
|
|
|
|
||||||||||||||
|
Other
2
|
|
|
|
||||||||||||||
| EBITDA from ongoing operations | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of profit (loss): | |||||||||||||||||
| Depreciation and amortization |
|
||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other |
|
||||||||||||||||
| Interest income |
|
||||||||||||||||
| Interest expense |
|
||||||||||||||||
|
Corporate expenses, net
3
|
|
||||||||||||||||
| Income (loss) from continuing operations before income tax |
|
||||||||||||||||
| Income tax expense (benefit) |
|
||||||||||||||||
| Net income (loss) from continuing operations |
|
||||||||||||||||
| Income (loss) from discontinued operations, net of tax |
|
||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||
|
1. Excludes related depreciation and amortization.
2. Includes segment allocated employee compensation benefit expenses. 3. Includes corporate depreciation and amortization. |
|||||||||||||||||
| Six Months Ended June 30, 2024 | |||||||||||||||||
| (In thousands) | Aluminum Extrusions | PE Films | Total | ||||||||||||||
| Net Sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of revenue: | |||||||||||||||||
| Add back freight |
|
||||||||||||||||
| Sales as shown in the consolidated statements of income (loss) | $ |
|
|||||||||||||||
| Less: | |||||||||||||||||
| Variable costs | $ |
|
$ |
|
$ |
|
|||||||||||
|
Manufacturing fixed costs
1
|
|
|
|
||||||||||||||
|
Selling, general and administrative costs
1
|
|
|
|
||||||||||||||
|
Other
2
|
|
|
|
||||||||||||||
| EBITDA from ongoing operations | $ |
|
$ |
|
$ |
|
|||||||||||
| Reconciliation of profit (loss): | |||||||||||||||||
| Depreciation and amortization |
|
||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other |
|
||||||||||||||||
| Interest income |
|
||||||||||||||||
| Interest expense |
|
||||||||||||||||
| Gain on investment in kaleo, Inc. |
|
||||||||||||||||
|
Corporate expenses, net
3
|
|
||||||||||||||||
| Income (loss) from continuing operations before income tax |
|
||||||||||||||||
| Income tax expense (benefit) |
|
||||||||||||||||
| Net income (loss) from continuing operations |
|
||||||||||||||||
| Income (loss) from discontinued operations, net of tax |
|
||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||
|
1. Excludes related depreciation and amortization.
2. Includes segment allocated employee compensation benefit expenses. 3. Includes corporate depreciation and amortization. |
|||||||||||||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | |||||||||
| Aluminum Extrusions | $ |
|
$ |
|
|||||||
| PE Films |
|
|
|||||||||
| Subtotal |
|
|
|||||||||
| General corporate |
|
|
|||||||||
| Cash and cash equivalents |
|
|
|||||||||
| Discontinued operations |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Aluminum Extrusions | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| PE Films |
|
|
|
|
|||||||||||||||||||
| Subtotal |
|
|
|
|
|||||||||||||||||||
| General corporate |
|
|
|
|
|||||||||||||||||||
| Discontinued operations |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Aluminum Extrusions | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| PE Films |
|
|
|
|
|||||||||||||||||||
| Subtotal |
|
|
|
|
|||||||||||||||||||
| Discontinued operations |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Net Sales by Geographic Area (a) | |||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| United States | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Exports from the United States to: | |||||||||||||||||||||||
| Asia |
|
|
|
|
|||||||||||||||||||
| Latin America |
|
|
|
|
|||||||||||||||||||
| Canada |
|
|
|
|
|||||||||||||||||||
| Europe |
|
|
|
|
|||||||||||||||||||
| Operations outside the United States: | |||||||||||||||||||||||
| Asia |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
(a) Export sales relate mostly to PE Films.
|
|||||||||||||||||||||||
| Net Sales by Product Group | |||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Aluminum Extrusions: | |||||||||||||||||||||||
| Nonresidential building & construction | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Consumer durables |
|
|
|
|
|||||||||||||||||||
| Automotive |
|
|
|
|
|||||||||||||||||||
| Residential building & construction |
|
|
|
|
|||||||||||||||||||
| Electrical |
|
|
|
|
|||||||||||||||||||
| Machinery & equipment |
|
|
|
|
|||||||||||||||||||
| Distribution |
|
|
|
|
|||||||||||||||||||
| Subtotal |
|
|
|
|
|||||||||||||||||||
| PE Films: | |||||||||||||||||||||||
| Surface protection films |
|
|
|
|
|||||||||||||||||||
| Overwrap packaging |
|
|
|
|
|||||||||||||||||||
| Subtotal |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Pricing under the ABL Facility (Basis Points) | ||||||||
| Quarter Average of Daily Availability |
Term Benchmark
Spread |
ABR
Spread |
||||||
| > 66% of $125 million aggregate commitment |
|
|
||||||
| ≤ 66% but > 33% of $125 million aggregate commitment |
|
|
||||||
| ≤ 33% of $125 million aggregate commitment |
|
|
||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Revenue and other items | |||||||||||||||||||||||
| Sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other income (expense), net |
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||
| Costs and expenses | |||||||||||||||||||||||
| Cost of goods sold |
|
|
|
|
|||||||||||||||||||
| Freight |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
| Research and development |
|
|
|
|
|||||||||||||||||||
| Amortization of intangibles |
|
|
|
|
|||||||||||||||||||
|
Interest expense
1
|
|
|
|
|
|||||||||||||||||||
| (Gain) loss on sale of business |
|
|
(
|
|
|||||||||||||||||||
| Total |
|
|
(
|
|
|||||||||||||||||||
| Income (loss) from discontinued operations before income tax |
(
|
|
|
|
|||||||||||||||||||
|
Income tax expense (benefit)
2
|
|
|
|
|
|||||||||||||||||||
| Income (loss) from discontinued operations, net of tax | $ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
|
1.
For the three and six months ended June 30, 2024, interest expense includes $
2.
An inconsequential income tax expense (benefit) was recognized during the three and six months ended June 30, 2025 primarily due to foreign tax credits generated from the final Brazilian withholding tax payment made during the periods, which offset the tax liability on the income from discontinued operations.
|
|||||||||||||||||||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | |||||||||
| Assets | |||||||||||
| Deferred income taxes | $ |
|
$ |
|
|||||||
| Total noncurrent assets of discontinued operations | $ |
|
$ |
|
|||||||
|
Liabilities
1
|
|||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued expenses |
|
|
|||||||||
| Total current liabilities of discontinued operations | $ |
|
$ |
|
|||||||
|
1.
The consolidated balance sheet of discontinued operations as of December 31, 2024 includes $
|
|||||||||||
| Six Months Ended June 30, | |||||||||||
| (In thousands) | 2025 | 2024 | |||||||||
| Operating activities: | |||||||||||
| Depreciation and amortization | $ |
|
$ |
|
|||||||
| Gain on the sale of divested business |
(
|
|
|||||||||
| Total | $ |
(
|
$ |
|
|||||||
| Investing activities: | |||||||||||
| Proceeds from the sale of Terphane | $ |
|
$ |
|
|||||||
| Capital expenditures |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| (In thousands) | ||||||||
|
Net income (loss) from continuing operations for the three months ended June 30, 2024
|
$ | 9,170 | ||||||
| Income tax expense (benefit) | (38) | |||||||
|
Income (loss) from continuing operations before income taxes for the three months ended June 30, 2024
|
9,132 | |||||||
| Change in income (loss) from increases (decreases) in the following items: | ||||||||
| Sales | 25,176 | |||||||
| Other income (expense), net | 1,063 | |||||||
| Total | 26,239 | |||||||
| Change in income (loss) from (increases) decreases in the following items: | ||||||||
| Cost of goods sold | (29,523) | |||||||
| Freight | (823) | |||||||
| Selling, general and administrative | (1,474) | |||||||
| Interest expense | (646) | |||||||
| Other | (93) | |||||||
| Total | (32,559) | |||||||
|
Income (loss) from continuing operations before income taxes for the three months ended June 30, 2025
|
2,812 | |||||||
| Income tax expense (benefit) | 984 | |||||||
|
Net income (loss) from continuing operations for the three months ended June 30, 2025
|
$ | 1,828 | ||||||
| Three Months Ended June 30, | ||||||||
| (In millions) | 2025 | 2024 | ||||||
| Aluminum Extrusions: | ||||||||
| (Gains) losses from sale of assets, investment writedowns and other items: | ||||||||
|
Consulting expenses for ERP/MES project
1
|
$ | 0.4 | $ | 0.8 | ||||
|
Storm damage to the Newnan, Georgia plant
1
|
(0.2) | 0.2 | ||||||
|
Legal fees associated with the Aluminum Extruders Trade Case and other matters
1
|
(0.2) | 0.3 | ||||||
| Total for Aluminum Extrusions | $ | — | $ | 1.3 | ||||
| PE Films: | ||||||||
| (Gains) losses associated with plant shutdowns, asset impairments and restructurings: | ||||||||
|
Richmond, Virginia Technical Center closure expenses, including severance
2
|
$ | — | $ | 0.1 | ||||
| Total for PE Films | $ | — | $ | 0.1 | ||||
| Corporate: | ||||||||
| (Gains) losses from sale of assets, investment writedowns and other items: | ||||||||
|
Professional fees associated with business development activities
1
|
$ | 1.3 | $ | — | ||||
|
Professional fees associated with remediation activities related to internal control over financial reporting
1
|
— | 0.4 | ||||||
|
Group annuity contract premium adjustment
3
|
— | (0.2) | ||||||
|
Professional fees associated with the transition to the ABL Facility
1
|
0.1 | — | ||||||
|
Proceeds on the sale of corporate-owned land
3
|
(1.4) | — | ||||||
| Total for Corporate | $ | — | $ | 0.2 | ||||
|
1. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income.
2. See Note 1 for additional information.
3. Included in “Other income (expense), net” in the condensed consolidated statements of income.
|
||||||||
| Three Months Ended June 30, | |||||||||||
| (In millions, except percentages) | 2025 | 2024 | |||||||||
| Floating-rate debt with interest charged on a rollover basis plus a credit spread: | |||||||||||
| Average total outstanding debt balance | $ | 61.2 | $ | 126.9 | |||||||
| Average interest rate | 6.7 | % | 9.1 | % | |||||||
| (In thousands) | ||||||||
|
Net income (loss) from continuing operations for the six months ended June 30, 2024
|
$ | 11,774 | ||||||
| Income tax expense (benefit) | 2,346 | |||||||
|
Income (loss) from continuing operations before income taxes for the six months ended June 30, 2024
|
14,120 | |||||||
| Change in income (loss) from increases (decreases) in the following items: | ||||||||
| Sales | 45,941 | |||||||
| Other income (expense), net | 1,048 | |||||||
| Total | 46,989 | |||||||
| Change in income (loss) from (increases) decreases in the following items: | ||||||||
| Cost of goods sold | (50,059) | |||||||
| Freight | (1,376) | |||||||
| Selling, general and administrative | (5,601) | |||||||
| Interest expense | (475) | |||||||
| Other | 462 | |||||||
| Total | (57,049) | |||||||
|
Income (loss) from continuing operations before income taxes for the six months ended June 30, 2025
|
4,060 | |||||||
| Income tax expense (benefit) | 1,560 | |||||||
|
Net income (loss) from continuing operations for the six months ended June 30, 2025
|
$ | 2,500 | ||||||
| Six Months Ended June 30, | ||||||||
| (In millions) | 2025 | 2024 | ||||||
| Aluminum Extrusions: | ||||||||
| (Gains) losses from sale of assets, investment writedowns and other items: | ||||||||
|
Consulting expenses for ERP/MES project
1
|
$ | 0.8 | $ | 1.4 | ||||
|
Storm damage to the Newnan, Georgia plant
1
|
(0.2) | 0.3 | ||||||
|
Legal fees associated with the Aluminum Extruders Trade Case and other matters
1
|
0.1 | 0.5 | ||||||
|
Aluminum premium charge as a result of unplanned maintenance interruptions
2
|
0.3 | — | ||||||
| Total for Aluminum Extrusions | $ | 1.0 | $ | 2.2 | ||||
| PE Films: | ||||||||
| (Gains) losses associated with plant shutdowns, asset impairments and restructurings: | ||||||||
|
Richmond, Virginia Technical Center closure expenses, including severance
3
|
$ | — | $ | 0.3 | ||||
|
Richmond, Virginia Technical Center lease modification
3
|
— | 0.3 | ||||||
| Total for PE Films | $ | — | $ | 0.6 | ||||
| Corporate: | ||||||||
| (Gains) losses from sale of assets, investment writedowns and other items: | ||||||||
|
Professional fees associated with business development activities
1
|
$ | 3.8 | $ | 0.2 | ||||
|
Professional fees associated with remediation activities related to internal control over financial reporting
1
|
0.2 | 1.3 | ||||||
|
Group annuity contract premium adjustment
4
|
0.1 | (0.2) | ||||||
|
Professional fees associated with the transition to the ABL Facility
1
|
0.2 | 0.2 | ||||||
|
Proceeds on the sale of corporate-owned land
4
|
(1.5) | — | ||||||
| Total for Corporate | $ | 2.8 | $ | 1.5 | ||||
|
1. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income.
2. Included in “Cost of Goods Sold” in the condensed consolidated statements of income.
3. See Note 1 for additional information.
4. Included in “Other income (expense), net” in the condensed consolidated statements of income.
|
||||||||
| Six Months Ended June 30, | |||||||||||
| (In millions, except percentages) | 2025 | 2024 | |||||||||
| Floating-rate debt with interest charged on a rollover basis plus a credit spread: | |||||||||||
| Average total outstanding debt balance | $ | 60.5 | $ | 130.0 | |||||||
| Average interest rate | 7.0 | % | 9.1 | % | |||||||
| Three Months Ended | Favorable/ | Six Months Ended | Favorable/ | |||||||||||||||||||||||||||||||||||
| (In thousands, except percentages) | June 30, | (Unfavorable) | June 30, | (Unfavorable) | ||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||||||
| Sales volume (lbs) | 40,690 | 34,906 | 16.6% | 78,608 | 68,747 | 14.3% | ||||||||||||||||||||||||||||||||
| Net sales | $ | 148,367 | $ | 119,413 | 24.2% | $ | 281,999 | $ | 233,636 | 20.7% | ||||||||||||||||||||||||||||
| Variable costs | 116,059 | 87,825 | (32.1)% | 219,582 | 172,610 | (27.2)% | ||||||||||||||||||||||||||||||||
|
Manufacturing fixed costs
1
|
11,760 | 9,881 | (19.0)% | 22,973 | 19,507 | (17.8)% | ||||||||||||||||||||||||||||||||
|
Selling, general and administrative costs
1
|
10,129 | 8,972 | (12.9)% | 19,541 | 15,770 | (23.9)% | ||||||||||||||||||||||||||||||||
|
Other
2
|
1,136 | (172) | (760.5)% | 1,462 | 302 | (384.1)% | ||||||||||||||||||||||||||||||||
| EBITDA from ongoing operations | $ | 9,283 | $ | 12,907 | (28.1)% | $ | 18,441 | $ | 25,447 | (27.5)% | ||||||||||||||||||||||||||||
| Depreciation & amortization | (4,093) | (4,446) | 7.9% | (8,319) | (8,988) | 7.4% | ||||||||||||||||||||||||||||||||
|
EBIT from ongoing operations
3
|
$ | 5,190 | $ | 8,461 | (38.7)% | $ | 10,122 | $ | 16,459 | (38.5)% | ||||||||||||||||||||||||||||
| Capital expenditures | $ | 2,386 | $ | 1,463 | $ | 4,757 | $ | 3,012 | ||||||||||||||||||||||||||||||
|
1. Excludes related depreciation and amortization
2. Includes segment allocated employee compensation benefit expenses
3. See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
|
||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Favorable/ | Six Months Ended | Favorable/ | |||||||||||||||||||||||||||||||||||
| (In thousands, except percentages) | June 30, | (Unfavorable) | June 30, | (Unfavorable) | ||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||||||
| Sales volume (lbs) | 9,798 | 10,548 | (7.1)% | 19,437 | 20,583 | (5.6)% | ||||||||||||||||||||||||||||||||
| Net sales | $ | 24,596 | $ | 29,197 | (15.8)% | $ | 50,134 | $ | 53,932 | (7.0)% | ||||||||||||||||||||||||||||
| Variable costs | 11,688 | 13,183 | 11.3% | 23,664 | 25,228 | 6.2% | ||||||||||||||||||||||||||||||||
|
Manufacturing fixed costs
1
|
3,243 | 3,115 | (4.1)% | 6,702 | 6,336 | (5.8)% | ||||||||||||||||||||||||||||||||
|
Selling, general and administrative costs
1
|
2,867 | 2,791 | (2.7)% | 5,459 | 5,307 | (2.9)% | ||||||||||||||||||||||||||||||||
|
Other
2
|
87 | (25) | (448.0)% | 76 | 24 | (216.7)% | ||||||||||||||||||||||||||||||||
| EBITDA from ongoing operations | $ | 6,711 | $ | 10,133 | (33.8)% | $ | 14,233 | $ | 17,037 | (16.5)% | ||||||||||||||||||||||||||||
| Depreciation & amortization | (1,230) | (1,317) | 6.6% | (2,480) | (2,645) | 6.2% | ||||||||||||||||||||||||||||||||
|
EBIT from ongoing operations
3
|
$ | 5,481 | $ | 8,816 | (37.8)% | $ | 11,753 | $ | 14,392 | (18.3)% | ||||||||||||||||||||||||||||
| Capital expenditures | $ | 295 | $ | 216 | $ | 882 | $ | 610 | ||||||||||||||||||||||||||||||
|
1. Excludes related depreciation and amortization
2. Includes segment allocated employee compensation benefit expenses
3. See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
|
||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| June 30, | June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Net Sales | ||||||||||||||||||||||||||
| Aluminum Extrusions | $ | 148,367 | $ | 119,413 | $ | 281,999 | $ | 233,636 | ||||||||||||||||||
| PE Films | 24,596 | 29,197 | 50,134 | 53,932 | ||||||||||||||||||||||
| Total net sales | 172,963 | 148,610 | 332,133 | 287,568 | ||||||||||||||||||||||
| Add back freight | 6,153 | 5,330 | 11,720 | 10,344 | ||||||||||||||||||||||
| Sales as shown in the condensed consolidated statements of income | $ | 179,116 | $ | 153,940 | $ | 343,853 | $ | 297,912 | ||||||||||||||||||
| EBITDA from Ongoing Operations | ||||||||||||||||||||||||||
| Aluminum Extrusions: | ||||||||||||||||||||||||||
| Ongoing operations: | ||||||||||||||||||||||||||
| EBITDA | $ | 9,283 | $ | 12,907 | $ | 18,441 | $ | 25,447 | ||||||||||||||||||
| Depreciation & amortization | (4,093) | (4,446) | (8,319) | (8,988) | ||||||||||||||||||||||
| EBIT | 5,190 | 8,461 | 10,122 | 16,459 | ||||||||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other | (57) | (1,649) | (1,225) | (2,816) | ||||||||||||||||||||||
| PE Films: | ||||||||||||||||||||||||||
| Ongoing operations: | ||||||||||||||||||||||||||
| EBITDA | $ | 6,711 | $ | 10,133 | $ | 14,233 | $ | 17,037 | ||||||||||||||||||
| Depreciation & amortization | (1,230) | (1,317) | (2,480) | (2,645) | ||||||||||||||||||||||
| EBIT | 5,481 | 8,816 | 11,753 | 14,392 | ||||||||||||||||||||||
| Plant shutdowns, asset impairments, restructurings and other | 1 | (80) | 1 | (584) | ||||||||||||||||||||||
| Total | 10,615 | 15,548 | 20,651 | 27,451 | ||||||||||||||||||||||
| Interest income | 6 | 5 | 11 | 25 | ||||||||||||||||||||||
| Interest expense | 1,785 | 1,139 | 2,798 | 2,323 | ||||||||||||||||||||||
| Gain on investment in kaleo, Inc. | — | 144 | — | 144 | ||||||||||||||||||||||
| Corporate expenses, net | 6,024 | 5,426 | 13,804 | 11,177 | ||||||||||||||||||||||
| Income (loss) from continuing operations before income taxes | 2,812 | 9,132 | 4,060 | 14,120 | ||||||||||||||||||||||
| Income tax expense (benefit) | 984 | (38) | 1,560 | 2,346 | ||||||||||||||||||||||
| Net income (loss) from continuing operations | 1,828 | 9,170 | 2,500 | 11,774 | ||||||||||||||||||||||
| Income (loss) from discontinued operations, net of tax | (97) | (378) | 9,332 | 306 | ||||||||||||||||||||||
| Net income (loss) | $ | 1,731 | $ | 8,792 | $ | 11,832 | $ | 12,080 | ||||||||||||||||||
|
Computations of Credit EBITDA (as defined in the ABL Facility) as of and for the
Twelve Months Ended June 30, 2025 *
|
|||||
|
Computations of Credit EBITDA for the twelve months ended June 30, 2025 (in thousands):
|
|||||
| Net income (loss) | $ | (64,814) | |||
| Plus: | |||||
| After-tax losses related to discontinued operations | 56,584 | ||||
| Total income tax expense for continuing operations | — | ||||
| Interest expense | 5,139 | ||||
| Depreciation and amortization expense for continuing operations | 22,301 | ||||
|
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $9,922)
|
23,301 | ||||
| Charges related to stock option grants and awards accounted for under the fair value-based method | — | ||||
| Losses related to the application of the equity method of accounting | — | ||||
| Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | — | ||||
| Fees, costs and expenses incurred in connection with the amendment process (Amendment No. 3 “ABL Transition”) | 412 | ||||
| Fees, costs and expenses incurred in connection with the amendment process (Amendment No. 5) | — | ||||
| Minus: | |||||
| After-tax income related to discontinued operations | — | ||||
| Total income tax benefits for continuing operations | (951) | ||||
| Interest income | (22) | ||||
| All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings | — | ||||
| Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method | — | ||||
| Income related to the application of the equity method of accounting | — | ||||
| Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | — | ||||
| Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions | — | ||||
| Credit EBITDA | $ | 41,950 | |||
| Fixed charge coverage ratio**: | |||||
| Credit EBITDA | $ | 41,950 | |||
| Unfinanced capital expenditures | $ | 13,873 | |||
| Fixed charges | $ | 5,716 | |||
| Fixed charge coverage ratio | 4.91 | ||||
|
*
Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and should not be considered as an alternative to either net income (loss) or to cash flow.
** Fixed Charge Coverage Ratio is computed as the ratio of (a) Credit EBITDA minus Unfinanced Capital Expenditures to (b) Fixed Charges.
|
|||||
| Source: Quarterly averages computed by the Company using London Metal Exchange daily aluminum cash prices plus the Midwest premium. | ||
| Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices. | ||
|
Source: Quarterly averages computed by Tredegar using monthly data provided by Oil Price Information Service (OPIS). In January 2023, OPIS reflected a 41 cents per pound non-market adjustment based on their estimate of the growth of discounts in the prior periods. The fourth quarter 2022 average rate of $0.60 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2022.
|
||
|
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.
|
||
| 10.1 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101 | XBRL Instance Document and Related Items. | |||||||
| 104 | Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101). | |||||||
| * | Denotes compensatory plans or arrangements or management contracts. | |||||||
| Tredegar Corporation | ||||||||||||||
| (Registrant) | ||||||||||||||
| Date: | August 8, 2025 | /s/ John M. Steitz | ||||||||||||
| John M. Steitz | ||||||||||||||
| President and Chief Executive Officer | ||||||||||||||
| (Principal Executive Officer) | ||||||||||||||
| Date: | August 8, 2025 | /s/ D. Andrew Edwards | ||||||||||||
| D. Andrew Edwards | ||||||||||||||
| Executive Vice President and Chief Financial Officer | ||||||||||||||
| (Principal Financial Officer) | ||||||||||||||
| Date: | August 8, 2025 | /s/ Frasier W. Brickhouse, II | ||||||||||||
| Frasier W. Brickhouse, II | ||||||||||||||
| Corporate Treasurer and Controller | ||||||||||||||
| (Principal Accounting Officer) | ||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| International Flavors & Fragrances Inc. | IFF |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|